TA
AST.WS

Teachers Advisors’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Teachers Advisors’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,925
Closed -$1K – 3147
2016
Q2 		$1K Buy
+2,925
New +$1.52K ﹤0.01% 3119

Other funds holding AST.WS

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Teachers Advisors's AST.WS Position: Q3 2016 in Review

Teachers Advisors sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2016, closing a stake of 2,925 shares — an estimated $1K sold.

Teachers Advisors first reported a position in AST.WS in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 37 funds tracked by Wall St. Rank hold AST.WS as of Q3 2016.

  • Teachers Advisors reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2016 after selling out during the quarter.
  • Teachers Advisors sold 2,925 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2016, an estimated $1K.
  • Teachers Advisors first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 1 quarter.
  • Teachers Advisors's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $1K in Q2 2016.
  • 37 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2016.

Based on Teachers Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.